Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,92 USD | 0,00% | -9,86% | -20,99% |
Attività
Numero di dipendenti: 66
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 11/07/19 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 18/05/23 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 14/06/21 |
Kevin Church
CTO | Chief Tech/Sci/R&D Officer | 39 | 01/01/16 |
Julie Rathbun
IRC | Investor Relations Contact | - | - |
Robert Renninger
PRN | Corporate Officer/Principal | - | 01/07/20 |
Samantha Willing
HRO | Human Resources Officer | - | 01/02 |
Mark Worthington
LAW | General Counsel | 58 | 01/06/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 27/01/22 |
John Fluke
BRD | Director/Board Member | 81 | 01/01/13 |
Joseph Edelman
BRD | Director/Board Member | 67 | 01/05/20 |
James Johnson
BRD | Director/Board Member | 67 | 01/08/20 |
Barbara Kosacz
BRD | Director/Board Member | 66 | 08/03/21 |
Mark Litton
CEO | Chief Executive Officer | 56 | 11/07/19 |
Michael Panzara
BRD | Director/Board Member | 57 | 18/03/22 |
Kelly Romano
CHM | Chairman | 62 | 14/12/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 38 326 652 | 31 772 063 ( 82,90 %) | 0 | 82,90 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-20,99% | 73,59 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione ATHA
- Società Athira Pharma, Inc.